Cat. #151213
Anti-HGF/SF [EGH2 4C12.1]
Cat. #: 151213
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 3-4 weeks
Target: Hepatocyte Growth Factor/Scatter Factor (HGF/SF)
Class: Monoclonal
Application: ELISA ; WB ; ELISA ; IHC ; WB
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Institute: University of Cambridge
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-HGF/SF [EGH2 4C12.1]
- Research fields: Cancer;Cell signaling and signal transduction
- Clone: EGH2 4C12.1
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Reactivity: Human
- Host: Mouse
- Application: ELISA ; WB ; ELISA ; IHC ; WB
- Description: HGF/SF is a member of the plasminogen related growth factor family, members of which are potent effectors of growth, movement and differentiation of epithelial and endothelial cells. HGF/SF may exhibit morphogenesis in adjacent cells. The membrane receptor for HGF/SF is the product of the proto-oncogene c-met, a receptor tyrosine kinase.
- Immunogen: Recombinant Human HGF/SF
- Isotype: IgG2b
- Myeloma used: NS0
- Recommended controls: Recombinant HGF/SF
Target Details
- Target: Hepatocyte Growth Factor/Scatter Factor (HGF/SF)
- Tissue cell line specificity: Recombinant HGF/SF
- Target background: HGF/SF is a member of the plasminogen related growth factor family, members of which are potent effectors of growth, movement and differentiation of epithelial and endothelial cells. HGF/SF may exhibit morphogenesis in adjacent cells. The membrane receptor for HGF/SF is the product of the proto-oncogene c-met, a receptor tyrosine kinase.
Applications
- Application: ELISA ; WB ; ELISA ; IHC ; WB
Handling
- Format: Liquid
- Concentration: 1 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Dry ice
References
- Clinical analysis of the effect of anti-allergy treatment on pocket-related complications following pacemaker implantation
- Bai et al. 2017. Exp Ther Med. 13(6):2876-2882. PMID: 28587353.
- In vitro and in vivo bioactivity of recombinant canine hepatocyte growth factor
- Arends et al. 2008. Vet J. 178(1):70-7. PMID: 18314358.
